| Jump to: | Authorized Access | | | Attribution | | | Authorized Requests |
- Study Description
-
Important Links and Information
-
Request access via Authorized Access
- Instructions for requestors
- Data Use Certification (DUC) Agreement
- Talking Glossary of Genetic Terms
Study to evaluate the molecular genetics of ccRCC through integrative analyses of tumors and tumorgrafts using multiple platforms in clinically annotated samples. Genome and exome data for patients giving consent to have the information available on a public, secure, database is being submitted.
- Study Design:
- Case-Control
- Study Type:
- Case Set
- Total number of consented subjects: 3
- Subject Sample Telemetry Report (SSTR)
-
Request access via Authorized Access
- Authorized Access
- Publicly Available Data
- Link to other NCBI resources related to this study
- Molecular Data
-
Type Source Platform Number of Oligos/SNPs SNP Batch Id Comment Exome Sequencing Illumina Genome Analyzer II N/A N/A Whole Genome Genotyping Affymetrix AFFY_6.0 934940 52074 Gene Expression Affymetrix Human Genome U133 Plus 2.0 Array N/A N/A - Study History
- Whole-Genome sequencing of a ccRCC tumor/normal pair
- Exome Sequencing for a ccRCC tumor/normal pair
- Exome Sequencing for a ccRCC tumor/metastasis/normal trio
- Selected Publications
- Diseases/Traits Related to Study (MeSH terms)
-
- Primary Phenotype: Carcinoma, Renal Cell
- Urogenital Neoplasms
- Urologic Diseases
- Authorized Data Access Requests
- Study Attribution
-
-
Principal Investigator
- James Brugarolas, MD, PhD. UT Southwestern Medical Center, Dallas, TX, USA.
-
Co-Investigator
- Samuel Peña-Llopis, PhD. UT Southwestern Medical Center, Dallas, TX, USA.
-
Funding Sources
- 2007062. Clinical Scientist Development Award from the Doris Duke Charitable Foundation, New York, NY, USA.
- RP101075. Cancer Prevention and Research Institute of Texas (CPRIT), Austin, TX, USA.
- Virginia Murchison Linthicum Endowment Scholar, UT Southwestern Medical Center, Dallas, TX, USA.
-
Principal Investigator